Comparison of grapiprant and meloxicam for management of postoperative joint pain in dogs: A randomized, double‐blinded, prospective clinical trial
Anaelle Cassemiche,
Sarah Schoffit,
Mathieu Manassero
et al.
Abstract:BackgroundGrapiprant is a novel anti‐inflammatory drug approved for the treatment of pain associated with osteoarthritis in dogs.ObjectiveCompare the efficacy of grapiprant vs meloxicam for the management of postoperative joint pain in dogs.AnimalsForty‐eight dogs presented with cranial cruciate ligament disease and treated by tibial plateau leveling osteotomy (TPLO) between May 2020 and May 2022.MethodsIn this randomized, double blinded, prospective clinical trial, client‐owned dogs with naturally occurring u… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.